10x Genomics, Inc. revenue by segment TXG

Annual Quarterly

10x Genomics, Inc. splits its revenue into 8 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Chromium Consumables at $88.5 million, 59% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	617	151	151	166	149	173	155	165	152
Product And Service Revenue	—	—	—	—	—	—	—	165 share 99.9%	—
Chromium Consumables	371 +1.8% share 60.1%	88 +3.1% share 58.6%	89 +5.7% share 58.9%	101 +3.1% share 60.7%	93 -4.2% share 62.1%	86 share 49.6%	84 share 54.3%	98 share 59.2%	97 share 63.7%
Spatial Consumables	160 +19.9% share 25.9%	42 share 28.0%	41 +30.9% share 27.1%	41 +14.4% share 24.7%	35 +19.2% share 23.7%	—	31 share 20.2%	36 share 21.7%	30 share 19.6%
Instruments	—	—	11 share 7.5%	—	—	—	—	—	—
Services	36 +22.6% share 5.9%	11 +26.0% share 7.1%	9 +15.4% share 5.9%	8 +15.3% share 5.1%	—	8 share 4.9%	8 share 4.9%	7 share 4.5%	6 share 4.2%
Spatial Instruments	27 -36.4% share 4.4%	5 -47.8% share 3.0%	—	9 -30.2% share 5.6%	7 -38.0% share 4.7%	9 share 5.1%	9 share 5.7%	13 share 8.1%	11 share 7.5%
Chromium Instruments	19 -36.0% share 3.1%	3 -46.1% share 2.0%	5 -11.7% share 3.5%	6 -44.1% share 3.7%	5 -35.5% share 3.3%	6 share 3.3%	6 share 3.8%	11 share 6.6%	8 share 5.0%
Licensing And Royalty Revenue	4 -90.6% share 0.7%	2 -93.0% share 1.3%	1 -94.4% share 0.6%	0 +207.2% share 0.2%	1 +934.7% share 0.7%	28 share 16.0%	17 share 11.0%	0 share 0.1%	0 share 0.1%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: TXG (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Pleasanton, CA
SEC filer status: Large accelerated filer
SEC CIK: 1770787

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.